Skip to content

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

Date: January 29, 2025

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and Annex 1 is now available from the International Council for Harmonization (ICH). Access the guideline here.

ICH E6 (R3) provides a unified standard to facilitate the mutual acceptance of clinical trial data across ICH member countries and regulatory authorities. Building on key concepts from ICH E8 (R1), the guideline introduces principles and annexes that expand on these concepts, ensuring applicability across different trial designs. The update emphasizes a proportionate, risk-based approach, encouraging innovation, technology adoption, and patient-centricity in clinical research.

This milestone represents a significant advancement in global clinical trial standards, enhancing efficiency, digital data utilization, and the acceleration of drug development.

The ACDM DMEG Regulatory Considerations group will assess the impact of this guidance on data management (DM) processes and release recommendations on implementation.

Discussions around regulatory developments and their impact on data management will be part of the broader conversations at ACDM25.

 


 

Explore More News

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Read More

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Read More

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .

Read More

New MHRA Guidance

The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .

Read More

FDA Guidance for Industry 

The FDA has issued a final guidance to provide information on risk-based approaches to . . .

Read More

Guideline on computerised systems and electronic data in clinical trials

The European Medicines Agency (EMA) have published the new guidelines on computerised . . .

Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .

Read More

Recommendation paper on decentralised elements in clinical trials

Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .

Read More

Welcome George Clinical as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .

Read More

Welcome Clinion as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .

Read More

Welcome ClinoSol Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .

Read More

CTU DMEG Update

The CTU DMEG has been actively discussing common problems that data managers face in . . .

Read More